The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Characterization of [Nphe1]nociceptin(1‐13)NH2, a new selective nociceptin receptor antagonist
Open accessAbstract
Nociceptin (orphanin FQ) is a novel neuropeptide capable of inducing a variety of biological actions via activation of a specific G‐protein coupled receptor. However, the lack of a selective nociceptin receptor antagonist has hampered our understanding of nociceptin actions and the role of this peptide in pathophysiological states. As part of a broader programme of research, geared to the identification and characterization of nociceptin receptor ligands, we report that the novel peptide [Nphe 1]nociceptin(1‐13)NH 2 acts as the first truly selective and competitive nociceptin receptor antagonist and is devoid of any residual agonist activity. [Nphe 1]nociceptin(1‐13)NH 2 binds selectively to recombinant nociceptin receptors expressed in Chinese hamster ovary (CHO) cells (p Ki 8.4) and competitively antagonizes the inhibitory effects of nociceptin (i) on cyclic AMP accumulation in CHO cells (pA 2 6.0) and (ii) on electrically evoked contractions in isolated tissues of the mouse, rat and guinea‐pig with pA 2 values ranging from 6.0 to 6.4. [Nphe 1]nociceptin(1‐13)NH 2 is also active in vivo, where it prevents the pronociceptive and antimorphine actions of intracerebroventricularly applied nociceptin, measured in the mouse tail withdrawal assay. Moreover, [Nphe 1]nociceptin(1‐13)NH 2 produces per se a dose dependent, naloxone resistant antinociceptive action and, at relatively low doses, potentiates morphine‐induced analgesia. Collectively our data indicate that [Nphe 1]nociceptin(1‐13)NH 2, acting as a nociceptin receptor antagonist, may be the prototype of a new class of analgesics. British Journal of Pharmacology (2000) 129, 1183–1193; doi:10.1038/sj.bjp.0703169
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722
Cited by
The Molecular and Behavioral Pharmacology of the Orphanin FQ/Nociceptin Peptide and Receptor Family
Mogil, J. S., & Pasternak, G. W. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01502-3 · Cited by 441
Pharmacology of nociceptin and its receptor: a novel therapeutic target
Calo', G., Guerrini, R., Rizzi, A., Salvadori, S., & Regoli, D. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703219 · Cited by 437
Self-citationThe nociceptin/orphanin FQ receptor: a target with broad therapeutic potential
Lambert, D. G. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2572 · Cited by 357
Self-citationToll, L., Bruchas, M. R., Calo', G., Cox, B. M., & Zaveri, N. T. (2016) · Pharmacological Reviews · doi:10.1124/pr.114.009209 · Cited by 297
Self-citationOpioid-induced hyperalgesia: abnormal or normal pain?
Simonnet, G., & Rivat, C. (2003) · NeuroReport · doi:10.1097/00001756-200301200-00001 · Cited by 273
Metadata
- Authors
- Calo', G., Guerrini, R., Bigoni, R., Rizzi, A., Marzola, G., Okawa, H., Bianchi, C., Lambert, D. G., Salvadori, S., & Regoli, D.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2000-03
- Volume
- 129
- Issue
- 6
- Pages
- 1183-1193
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2039648325
- Cited by
- 190
- References
- 1
- FWCI
- 10.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Characterization of [Nphe1]nociceptin(1‐13)NH2, a new selective nociceptin receptor antagonist. https://app.cochat.ai/papers/10.1038/sj.bjp.0703169
- The paper
- Calo', G., Guerrini, R., Bigoni, R., Rizzi, A., Marzola, G., Okawa, H., Bianchi, C., Lambert, D. G., Salvadori, S., & Regoli, D. (2000). Characterization of [Nphe1]nociceptin(1‐13)NH2, a new selective nociceptin receptor antagonist. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0703169
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.